We begin where others cease …

The decoding of human genome represents a milestone in modern medicine that enables the development of new analytical methods and therapies in molecular medicine and cell biology as well as in diagnostics.

New generations of biomarkers and therefore active components support the development of new therapeutic concepts. The integration of molecular diagnostics and therapy opens a door towards personalized medicine in future years and decades. The establishment of the interface between these two areas poses a challenge for molecular biological research and development as
well as for the biotechnological industry.

ProteaImmun's expertise in the recombinant protein expression, especially in human proteases and in the development of antibodies and modern methods of detection and analysis of proteins, enables us to offer customized solutions and support with single components as well as with complete molecular diagnostic systems.

With our highly motivated team of competent biologists, biochemists and medical scientists we want to offer you the
best support regarding the development of new solutions tailored to the customer’s needs. The location of ProteaImmun in Berlin-Buch Campus is in the middle of a perfect technological and scientific environment, as a systemsprovider for molecular diagnostics and theragnostic applications.

Our competence is the basis of your trust!